MedTech accelerator
London’s MedTech accelerator drives new health innovations
The Imperial-led MedTech SuperConnector is spurring the development of pioneering diagnostic tools and medical devices.
Stories tagged with 'Comms strategy Entrepreneurial ecosystem'
Psychotherapy with MDMA
MDMA and psychotherapy in combination could be used to treat alcoholism
Awakn Life Sciences is using an Imperial study into MDMA-assisted psychotherapy to create a treatment for alcoholism that it aims to offer in clinics.
Grassroots movements
Five lessons from the founder of the Me Too movement
Founder of the Me Too movement, Tarana Burke, called on students to use their spheres of influence to make change at an Imperial event.
Novel Parkinson's Therapy
Imperial medtech startup Charco Neurotech raises $10 million
Seed round will support the launch of CUE1, a novel therapy with a waiting list of more than 6000 people
Climate hackathon
ClimateX Hackathon winners showcased at COP26
The winners of a student climate innovation competition have presented their innovation, an app that shows the impact of rising sea levels, at COP26.
Resilient water networks
Imperial water technology startup Inflowmatix acquired by SUEZ
Imperial startup Inflowmatix will continue to accelerate the digital transformation of the water sector after its acquisition by SUEZ.
Decarbonising business
Five ways universities are helping businesses decarbonise
Universities like Imperial are supporting companies to achieve the transformation in technologies and business models needed to reach net zero.
Breast cancer diagnostic
Imperial partnered with DNA Electronics to develop breast cancer diagnostic test
Imperial has partnered with healthcare company DNA Electronics (DNAe) to develop a new platform for monitoring breast cancer.
Audio
Pod chat
Podcast: Healthy environments, polio progress, and colour-change hygiene checker
In this edition: What makes a healthy environment, the final steps to eliminate polio, and a test for proper cleaning.
CF Gene Therapy deal
Accelerated development of a potential treatment for cystic fibrosis
The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim.
